CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 51 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,783,029 | +6.8% | 152,526 | +22.8% | 0.00% | 0.0% |
| Q2 2023 | $1,669,234 | -3.6% | 124,199 | +18.9% | 0.00% | 0.0% |
| Q1 2023 | $1,731,433 | -10.5% | 104,429 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $1,935,051 | +11.0% | 104,035 | -23.5% | 0.00% | 0.0% |
| Q3 2022 | $1,744,000 | +82.4% | 135,968 | -0.3% | 0.00% | – |
| Q2 2022 | $956,000 | +121.3% | 136,350 | +161.8% | 0.00% | – |
| Q1 2022 | $432,000 | -91.7% | 52,088 | -97.6% | 0.00% | -100.0% |
| Q4 2015 | $5,211,000 | -18.3% | 2,127,100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,381,000 | -38.5% | 2,127,100 | -15.3% | 0.00% | -40.0% |
| Q2 2015 | $10,373,000 | -4.6% | 2,511,600 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $10,875,000 | +45.8% | 2,511,600 | 0.0% | 0.01% | +66.7% |
| Q4 2014 | $7,459,000 | -10.6% | 2,511,600 | 0.0% | 0.00% | -25.0% |
| Q3 2014 | $8,339,000 | +27.3% | 2,511,600 | -3.0% | 0.00% | +33.3% |
| Q2 2014 | $6,551,000 | – | 2,589,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |